Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue 5, 2008, Pages 529-534

  Benki, Sarah ^a,b   Mostad, Sara B ^b   Richardson, Barbra A ^a,b   Mandaliya, Kishorchandra ^c   Kreiss, Joan K ^b   Overbaugh, Julie ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Department of Obstetrics and Gynaecology   (Kenya)

Author keywords

Cervical; Genital shedding; HIV 1; HIV 1 DNA; Hormones; Infectivity

Indexed keywords

LUTEINIZING HORMONE; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; PRIORITY JOURNAL; UTERINE CERVIX MUCUS; UTERINE ENDOCERVIX; VIRUS SHEDDING;

ADULT; CD4 LYMPHOCYTE COUNT; CERVIX UTERI; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; VAGINA; VIRAL LOAD; VIREMIA; VIRUS SHEDDING;

EID: 41149102882     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318165b952     Document Type: Article

References (14)

1. Benki S, McClelland RS, Overbaugh J. Risk factors for human immunodeficiency virus type-1 acquisition in women in Africa. J Neurovirol. 2005;11(Suppl 1):58-65.
2. Benki S, Mostad SB, Richardson BA, et al. Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. J Infect Dis. 2004; 189:2192-2201.
3. Reichelderfer PS, Kovacs A, Wright DJ, et al. The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions. J Infect Dis. 2002;186:726-728.
4. Money DM, Arikan YY, Remple V, et al. Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus. Am J Obstet Gynecol. 2003;188:122-128.
5. Villanueva JM, Ellerbrock TV, Lennox JL, et al. The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions. J Infect Dis. 2002;185:170-177.
6. Goulston C, Stevens E, Gallo D, et al. Human immunodeficiency virus in plasma and genital secretions during the menstrual cycle. J Infect Dis. 1996;174:858-861.
7. Tuomala RE, O'Driscoll PT, Bremer JW, et al. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis. 2003;187: 375-384.
8. Mostad SB, Jackson S, Overbaugh J, et al. Cervical and vaginal shedding of human immunodeficiency virus type 1- infected cells throughout the menstrual cycle. J Infect Dis. 1998;178:983-991.
9. Benki S, McClelland RS, Emery S, et al. Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters. J Clin Microbiol. 2006;44:4357-4362.
10. Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis. 2004;190:1880-1888.
11. Pauk J, Huang ML, Brodie SJ, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000;343:1369-1377.
12. Ferin M, Jewelewicz R, Warren M. The Menstrual Cycle: Physiology, Reproductive Disorders, and Infertility. New York: Oxford University Press; 1993:67-68.
13. Ferenczy A, Wright TC. Anatomy and histology of the cervix. In: Kurman R, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York: Springer-Verlag; 2002:185-201.
14. Baeten JM, Overbaugh J. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Current HIV Research. 2003;1:69-86.